课题基金 / 基金详情

Synthesis of an antitumor active chelerythrine type alkaloid using Claisen rearrangement of a propargyl ether

Synthesis of an antitumor active chelerythrine type alkaloid using Claisen rearrangement of a propargyl ether
利用炔丙醚克莱森重排合成抗肿瘤活性白屈菜红碱型生物碱
批准号:
61570992
负责人:
ISHII Hisashi
金额:
$1.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1986
资助国家:
日本
项目状态:
已结题
起止时间:
1986 至 1988

项目摘要

项目成果

ISHII Hisashi的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. Claisen Rearrangement of Aryl Propargyl Ether in the Presence of CsF: We found that Claisen rearrangement of the propargyl ether (1) in the presence of CsF , easily prepared, gave only the furan (3) but not the pyran (2) . This new reaction was examined in detail using the -naphthol derivative (4). The following facts were found on formation of a furan ring: (a) The best solvent was PHNET_2. (b) Other additives ex-cept CsF could not act. (c) A catalytic amount of CsF was enough, but practically about equimolar amount of it was needed. Heating 5__-, 6__- and the acetal of 7__- in PhNEt_2 containing CsF gave the corresponding furans in good yields, respectively, indicating generality of the reaction.KA2. Cleavage of the Furan Ring: The furan (8) derived from 7__- was used as a model compound for cleavage reaction of a furan ring. Successive treatment of 8__- with a stoichiometric amount of OsO_4, NaIO_4, and dil. NaHCO_3 aq. provided the desired salicylaldehyde (9) in satisfactory yield.3. Synthesis of Chelerythrine (11): The aldehyde (10) was prepared from 3__- using the method mentioned adove. Treatment of the methyl ether of 10__- with TsOH resulted in deprotection and cyc-lization to give chelerythrine (11). We succeeded in synthesizing a chelerythrine type alkaloid.KA
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthetic Studies on the Antitumor Benzo[c]phenanthridine Alkaloids Directing toward Medicinals Development
  • 批准号:
    62870085
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
  • 资助金额:
    $6.46万
  • 财政年份:
    1987
  • 负责人:
    ISHII Hisashi
  • 依托单位: